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Background: Coronary artery spasm (CAS) is a major cause of myocardial ischemia.
However, the incidence and clinical prognosis of diffuse CAS compared with focal
CAS has not been fully investigated. We compared diffuse CAS with focal CAS in
patients (pts) with vasospastic angina based on 3-year clinical outcomes.
Methods: A total of 2,797 consecutive pts without signiﬁcant coronary artery disease
(CAD) who underwent Acetylcholine (Ach) provocation test were enrolled between
Nov. 2004 and Oct. 2010. Patients were divided into three groups according to Ach
test results and spasm extent (CAS negative; n¼1,188, Diffuse CAS,  20mm;
n¼1,344, Focal CAS, < 20mm; n¼265).
Results: Baseline characteristics were similar between diffuse and focal groups.
Angiographically, the diffuse group showed higher incidence of multi-vessel spasm
(39.2% vs. 10.1%, p<0.01) and ECG changes (6.7 vs. 3.3%. p¼0.03), whereas the
focal group had more myocardial bridges (24.3 vs. 40.8%, p<0.01). Three-year
clinical outcomes including mortality, cardio & cerebro-vascular disease and recurrent
chest pain were similar between the two groups. When respectively compared with
CAS negative group, only diffuse CAS was shown to be an independent predictor of
recurrent chest pain (6.7% vs. 3.7%, p<0.01), even after adjustment using propensity
score matching (OR; 1.63, 95% C.I; 1.08-2.46).
Conclusion: In this study, diffuse CAS was associated with adverse 3-year clinical
outcomes. Therefore, intensive anti-anginal management and close clinical follow up
would be needed for pts who showed diffuse CAS during Ach provocation test.P
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Background: Chronic total occlusion (CTO) intervention is still challenging because
of the limited procedural success rate and high target failure. The impact of percu-
taneous coronary intervention (PCI) for CTO in the left anterior descending artery
(LAD) is not clear. We evaluated the 12-month clinical outcomes between PCI and
optimal medical therapy (OMT) for LAD-CTO patients.
Methods: A total of 218 consecutive CTO patients were divided into 2 groups ac-
cording to treatment strategy; PCI group (n¼117) and OMT group (n¼101). 12-month
clinical outcomes were compared between the two groups.
Results: At baseline, the OMT group had a higher prevalence of elderly, congestive
heart failure, left main disease, multivessel disease, multivessel CTO, LCX-CTO,
RCA-CTO, and well-developed collaterals (grade 2), whereas the PCI group had a
higher prevalence of current smokers. Clinical outcomes at 12 months after baseline
adjustment by multivariate analysis showed similar major hard endpoints including
mortality, myocardial infarction, revascularization and major adverse cardiac events
(Table).
Conclusion: In our study, PCI seems to have no beneﬁt over OMT in left anterior
descending artery chronic total occlusion. Long-term follow up with a larger study
population will be necessary for further evaluation.TCTAP A-180
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Background: It has been reported that signiﬁcant endothelial dysfunction or clinically
evident vasospasm can be associated with drug-eluting stents (DESs). However, the
impact of DES associated coronary artery spasm (CAS) on 3-year clinical outcomes in
patients (pts) with vasospastic angina has not been fully elucidated.R/High Risk Patients: Diabetes, Heart Failure, Renal Failure, Others S51
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